-
Most Recent
Search Results
240 results for DDRX
Why Intel Stock Will Rise Sharply From Here
Intel’s multi-year lows will end when value investors bet on strong PC chip and graphics card sales rising from here.
Looks like This Momentum in Micron Stock Is for Real
One of the leaders of the semiconductor resurgence is Micron Technology (NASDAQ:MU). Micron stock is up nearly 13% this month, as of Thursday, Sept. 19.…
Why Micron Technology, Inc. (MU) Stock Will Gain 21%
Micron’s (MU) growth and earnings potential is overlooked by analysts, but MU stock holders will win when 3D XPoint rolls out.
Does Micron Technology, Inc. (MU) Stock Deserve All the Hype?
Micron (MU) shareholders are highly bullish on the company ahead of the earnings report due Thursday. Here’s what you need to know.
The 3 Most Undervalued Semiconductor Stocks to Buy in July 2024
Robust AI and automotive tech innovations are propelling undervalued semiconductor stocks as sales steadily increase.
3 Stocks to Supercharge Your Portfolio for 2024’s Second Act
Uncover top stocks to buy for the latter half of 2024, leveraging market divergence and growth opportunities in a dynamic economic landscape.
5 Stocks With Superb Sales Growth — BDSI DRRX AGX GORO MCC
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Superb Sales Growth — BDSI VICL DRRX AGX GORO
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Superb Sales Growth — CRIS DRRX AGX MCC FHCO
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Strong Sales Growth — CRIS DRRX AGX MCC FHCO
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Strong Sales Growth — DRRX AGX MCC FHCO QCOR
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Strong Sales Growth — BDSI DRRX AGX GORO MCC
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
4 Pharmaceutical Stocks to Sell Now
The ratings of four Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
5 Stocks With Prime Sales Growth — BDSI DRRX AGX PLUS PMT
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
Why Is Biodexa Pharmaceuticals (BDRX) Up 56% Today?
Biodexa Pharmaceuticals stock is up on Thursday with heavy trading of BDRX shares alongside positive clinical trial news.
Why Is GoodRx (GDRX) Stock Down Today?
GoodRx (GDRX) stock is slipping on Tuesday despite the healthcare company beating out estimates for the first quarter of 2022.
3 Health Care Technology Stocks to Sell Now
This week, the ratings of 3 Health Care Technology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall…
4 Health Care Technology Stocks to Sell Now
This week, 4 Health Care Technology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong…
Wait for GoodRx Stock to Fall Below $35
As GoodRx stock diversifies its platform monetization opportunities, GDRX shares could rebound to see new highs in the coming quarters.
4 Pharmaceuticals Stocks to Sell Now
This week, the overall grades of 4 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
4 Health Care Technology Stocks to Sell Now
The overall ratings of 4 Health Care Technology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F”…
4 Pharmaceuticals Stocks to Sell Now
The ratings of 4 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
3 – 10 of 240 results
